While hailing Govt’s move to rationalize and cap Trade Margins in Medical Devices to achieve the overall goal of affordable healthcare for all by making all critical and lifesaving medical devices available at affordable prices, Mr. Rajiv Nath, Forum Coordinator of Association of Indian Medical Device Industry (AiMeD) strongly emphasized that if the Government plans to bring down prices of Thinktank NITI-Aayog’s efforts to rationalise trade margin for those medical devices that are not under any form of price control has been labelled ‘half-baked,’ by civil society groups. On "We want sanity in trade margins for the medical devices sector, which should be between 40 to 60 per cent for the entire supply chain, that is from the first point of sale to the end user," CII Trade margin on medical devices as also on the quantum of the margins; there is a debate on the location of the “First Point of Sale” (from where to calculate the Trade Margins?) in case of imported medical devices. One view is that importers are also traders and the journey of trade margins should start from the import price itself. Govt set to identify a list of “essential medical devices”, expected to be a precursor to anti-profiteering measures such as capping trade margins in the range of 30-50%
Medical devices trade margins likely to be capped at 30% The government seems to have found a middle ground between demands of the domestic industry and global MNCs investment. While it has decided to abandon the price cap regime for medical devices (as in the case of stents and knee implants), a limit of 30% trade margin on medical devices is likely to be approved soon, the same people said. Rationalization of trade margins of medical devices may reduce MRP by 73 %. Margin controls would permit manufacturers of medical devices to continue to innovate and compete based on the value of the technology. The main aim of rationalisation of trade margins in medical devices should be not only to help consumers, but also allow rationalised and reasonable profits for traders, importers, distributors, The margin controls would permit manufacturers of medical devices to continue to innovate and compete based on the value of the technology. This will ultimately benefit the patient population in India.
advantage to importers of Medical Devices by attempting to equate prices of importers with Domestic Manufacturers and the MRP as basis of Trade Margin Are you experiencing unnecessary losses which are cutting into your margins? Today's global medical devices industry is changing fast. Healthcare providers
13 Feb 2020 US has been asking India to remove price caps on high-end medical devices under the proposed trade deal. Healthcare industry in India 15 Nov 2019 Importers have been lobbying to be kept outside the purview of trade margin rationalisation. By accepting their demand, the government would Niti Aayog along with NPPA(National Pharmaceutical Pricing Authority) is now considering switching the price cap model to trade margin cap model for better Domestic medical device industry hails Government's move to rationalise and cap trade margins in medical devices to achieve the overall goal of affordable Procure medical devices under public health schemes to increase The issue of rationalization of trade margins in medical device sector is already under
25 Jun 2018 Thinktank NITI-Aayog's efforts to rationalise trade margin for those medical devices that are not under any form of price control has been these goods have become China's leading medical device export categories. P . Torsekar, Office of Industries, U.S. International Trade Commission, 500 E Street , margins. Segment. Company. 2014 Revenues ($ million). Gross margin (%). Why IHI? 1. Exposure to U.S. companies that manufacture and distribute medical devices. 2. Targeted access to domestic medical device stocks. 3. Use to 9 Feb 2020 The government is of the view that the maximum retail price (MRP) of a device should be decided by adding the trade margin to the price at the 9 Jul 2018 Hyderabad: The Centre is considering rationalising trade margins for medical devices as capping their prices has not proved to be beneficial to